A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH09-12-0860
Issue:2010: 104/3 (Sep) pp. 421–653
Pages:531-535

A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissues

Online Supplementary Material

N. Shomron (1), N. Hamasaki-Katagiri (2), R. Hunt (2), K. Hershko (2), E. Pommier (2), S. Geetha (2), A. Blaisdell (2), A. Marple (3), I. Roma (3), J. Newell (2), C. Allen (2), S. Friedman (4), C. Kimchi-Sarfaty (2)

(1) Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; (2) Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA; (3) Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; (4) Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York, USA

Summary

Although ADAMTS13, the von Willebrand factor (VWF)-cleaving protease, is expressed in a range of tissues, the physiological significance of tissue-specific ADAMTS13 alternative splicing isoforms have yet to be clarified. Screening a panel of human tissues and cell lines revealed a spliced ADAMTS13 transcript in hepatic stellate cells and a hepatoma cell line that retains the 25th intron. A nonsense codon within the intron truncates the protease, which gains 64 novel amino acids in lieu of both CUB domains. This isoform, while retaining VWF-cleaving capability, accumulates intracellularly and its biological inaccessibility may prevent its participation in regulating haemostasis and other physiologic functions.

Keywords

ADAMTS13, TTP, alternative splicing, intron retention, CUB domain

DOI

http://dx.doi.org/10.1160/TH09-12-0860

You may also be interested in...

1.

Reinhard Schneppenheim 1, Johanna A. Kremer Hovinga2 , Tim Becker3 , Ulrich Budde4 , Diana Karpman 5, Wolfgang Brockhaus6 , Ingrid Hrachovinová 7, Bartosz Korczowski8 , Florian Oyen 1 , Šimon Rittich7 , Johannes von Rosen 9, Geir E. Tjønnfjord10, J

Thrombosis and Haemostasis 2006 96 1: 3-6

http://dx.doi.org/10.1160/TH05-12-0817

2.

Manfred Rieger 1*, Silvia Ferrari 1*, Johanna A. Kremer Hovinga 2 , Christian Konetschny 1 , Andrea Herzog 1 , Letizia Koller 1 , Alfred Weber 3 , Giuseppe Remuzzi 4 , Michael Dockal 1 , Barbara Plaimauer 1 , Friedrich Scheiflinger 1

Thrombosis and Haemostasis 2006 95 2: 212-220

http://dx.doi.org/10.1160/TH05-08-0550

3.

R. Schneppenheim (1), U. Budde (2)

Hämostaseologie 2011 31 4: 275-280

http://dx.doi.org/10.5482/ha-1167



Articles

You've 252 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...